Sep 2026· International Journal on Biological Sciences· Vol 22, pp. 7845 - 7861· 0 citations· 41 references
Medicine
TL;DR
Findings uncover an OTUD4-FXR1-HIF1A signaling axis that promotes glycolysis, which in turn functionally drives gastric cancer progression, and thereby provides a potential prognostic biomarker and therapeutic target.
Abstract
Ubiquitination and deubiquitination play critical roles in gastric cancer progression, yet systematic investigations of ubiquitin-regulating proteins in gastric cancer (GC) remain limited. To identify key regulators, we performed Ubiquitin-Focused CRISPR-Cas9 growth-based screening in GC cells and identified the deubiquitinase OTUD4 as a candidate gene promoting tumor growth. Functionally, OTUD4 was found to act as an oncogene by promoting the proliferation and metastasis of GC cell. Mechanistically, OTUD4 interacts with FXR1 through its N-terminal region (1-245 aa), and mutation of the catalytic cysteine residue (C45A) markedly impairs this interaction. OTUD4-mediated deubiquitination removes K48-linked polyubiquitin chains from FXR1, thereby protecting FXR1 from proteasomal degradation and increasing its stability. The resulting accumulation of FXR1 enhances HIF1A mRNA stability, leading to increased HIF1A expression. Consequently, HIF1A activates glycolytic programs and promotes the malignant progression of gastric cancer. Clinically, OTUD4 expression was significantly higher in tumor tissues, and higher OTUD4 levels were linked to decreased overall survival. Importantly, OTUD4 and FXR1 expression levels show a positive correlation in human GC samples. Collectively, these findings uncover an OTUD4-FXR1-HIF1A signaling axis that promotes glycolysis, which in turn functionally drives gastric cancer progression, and thereby provides a potential prognostic biomarker and therapeutic target.
It is shown that AP4M1 is markedly upregulated in HCC, correlates with unfavorable prognosis, and is functionally involved in driving HCC progression, providing a critical theoretical basis for AP4M1-targeted therapeutic strategies in HCC.
Yuan-Hao Peng, K. Kang, Xuanxuan Li et al.· Cancer Letters· 0 citations
Ovarian cancer (OV) remains one of the most lethal gynecological malignancies, with limited effective early detection strategies and therapeutic options. Despite advances in platinum-based chemotherapy and targeted therapies, including PARP inhibitors and immune checkpoint inhibitors, treatment failure and recurrence r...
The FEN1/EIF4A3/MUC1-C axis is established as a novel mechanism driving LUAD progression by concurrently regulating intrinsic malignancy and extrinsic immune evasion, presenting FEN1 targeting as a promising dual-hit therapeutic strategy.
Min Wu, Ben-Meng Wu, Xue-Bing Yan et al.· Cell Death and Disease· 0 citations
EIF2AK2, also known as PKR, is a stress-responsive kinase that regulates multiple cellular processes, including autophagy, apoptosis, and tumor progression. However, the mechanisms underlying EIF2AK2 stability and function in bladder cancer (BLCA) remain underexplored. In this study, we investigated the mechanisms gove...
It is demonstrated that UCHL3 plays a pivotal role in stabilizing PKM2, which in turn facilitates glycolysis and tumorigenesis in BCa, suggesting that UCHL3 may prove to be a potential target for the treatment of BCa.
Geng-Sheng Shi, Yan-Yan Wu, Ying-Ying Wang et al.· Frontiers in Oncology· 0 citations
Experimental data indicated that P4HA3 facilitated GC cell proliferation, migration and invasion, and enhanced glycolytic activity and increased the expression of key glycolysis-related proteins, suggesting that P4HA3 may induce a broader metabolic activation rather than an exclusively glycolytic shift.
Tao Wang, Xiao Xu, C. Jin et al.· Pakistan Journal of Pharmace...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.